Pulse lineResearch With Heart Logo

ARIC Publications

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
K
Koton S, Schneider ALC, Rosamond WD, Shahar E, Sang Y, Gottesman RF. "Stroke incidence and mortality trends in US communities, 1987 to 2011." JAMA. 2014;312(3):259-68.
Koton S, Sang Y, Schneider ALC, Rosamond WD, Gottesman RF. "Trends in Stroke Incidence Rates in Older US Adults: An Update From the Atherosclerosis Risk in Communities (ARIC) Cohort Study." JAMA Neurol. 2020;77(1):109-113.
Koton S, Wruck L, Quibrera PMiguel, et al. "Temporal trends in validated ischaemic stroke hospitalizations in the USA." Int J Epidemiol. 2019;48(3):994-1003.
Köttgen A, Hsu CC, Coresh J, et al. "The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of US adults." Am J Kidney Dis. 2008;52(5):868-75.
Köttgen A, Yang Q, Shimmin LC, et al. "Association of estimated glomerular filtration rate and urinary uromodulin concentrations with rare variants identified by UMOD gene region sequencing." PLoS One. 2012;7(5):e38311.
Köttgen A, Russell SD, Loehr LR, et al. "Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study." J Am Soc Nephrol. 2007;18(4):1307-15.
Köttgen A, Glazer NL, Dehghan A, et al. "Multiple loci associated with indices of renal function and chronic kidney disease." Nat Genet. 2009;41(6):712-7.
Köttgen A, Kao W HL, Hwang S-J, et al. "Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies." BMC Med Genet. 2008;9:49.
Köttgen A, Hwang S-J, Rampersaud E, et al. "TCF7L2 variants associate with CKD progression and renal function in population-based cohorts." J Am Soc Nephrol. 2008;19(10):1989-99.
Köttgen A, Albrecht E, Teumer A, et al. "Genome-wide association analyses identify 18 new loci associated with serum urate concentrations." Nat Genet. 2013;45(2):145-54.
Köttgen A, Hwang S-J, Larson MG, et al. "Uromodulin levels associate with a common UMOD variant and risk for incident CKD." J Am Soc Nephrol. 2010;21(2):337-44.
Köttgen A, Pattaro C, Böger CA, et al. "New loci associated with kidney function and chronic kidney disease." Nat Genet. 2010;42(5):376-84.
Kou M, Ding N, Ballew SH, et al. "Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease." Arterioscler Thromb Vasc Biol. 2021;41(3):1229-1238.
Kovesdy CP, Coresh JJ, Ballew SH, et al. "Past Decline Versus Current eGFR and Subsequent ESRD Risk." J Am Soc Nephrol. 2016;27(8):2447-55.
Kowalski MH, Qian H, Hou Z, et al. "Use of >100,000 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium whole genome sequences improves imputation quality and detection of rare variant associations in admixed African and Hispanic/Latino populations." PLoS Genet. 2019;15(12):e1008500.
Kraja AT, Cook JP, Warren HR, et al. "New Blood Pressure-Associated Loci Identified in Meta-Analyses of 475 000 Individuals." Circ Cardiovasc Genet. 2017;10(5).
Kraja AT, Chasman DI, North KE, et al. "Pleiotropic genes for metabolic syndrome and inflammation." Mol Genet Metab. 2014;112(4):317-38.
Kraja AT, Liu C, Fetterman JL, et al. "Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic Traits." Am J Hum Genet. 2019;104(1):112-138.
Kraja AT, Vaidya D, Pankow JS, et al. "A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium." Diabetes. 2011;60(4):1329-39.
Krishnan S, Steffen LM, Paton CM. "Impact of dietary fat composition on prediabetes: a 12-year follow-up study." Public Health Nutr. 2017;20(9):1617-1626.
Krishnappa D, Wang W, Rooney MR, et al. "Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study." Int J Cardiol. 2021.
Kritchevsky SB, Tell GS, Shimakawa T, et al. "Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study." Am J Clin Nutr. 1998;68(3):726-33.
Kritchevsky SB, Shimakawa T, Tell GS, et al. "Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study." Circulation. 1995;92(8):2142-50.
Krop JS, Coresh J, Chambless LE, et al. "A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study." Arch Intern Med. 1999;159(15):1777-83.
Kshirsagar AV, Moss KL, Elter JR, Beck JD, Offenbacher S, Falk RJ. "Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study." Am J Kidney Dis. 2005;45(4):650-7.
Kshirsagar AV, Offenbacher S, Moss KL, Barros SP, Beck JD. "Antibodies to periodontal organisms are associated with decreased kidney function. The Dental Atherosclerosis Risk In Communities study." Blood Purif. 2007;25(1):125-32.
Kshirsagar AV, Coresh J, Brancati F, Colindres RE. "Ankle brachial index independently predicts early kidney disease." Ren Fail. 2004;26(4):433-43.
Kshirsagar AV, Carpenter M, Bang H, Wyatt SB, Colindres RE. "Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease." Am J Med. 2006;119(2):133-41.
Kubota Y, London SJ, Cushman M, et al. "Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study." J Thromb Haemost. 2016;14(12):2394-2401.
Kubota Y, Folsom AR, Ballantyne CM. "Lipoprotein(a) and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:63-67.
Kubota Y, Evenson KR, Maclehose RF, Roetker NS, Joshu CE. "Physical Activity and Lifetime Risk of Cardiovascular Disease and Cancer." Med Sci Sports Exerc. 2017;49(8):1599-1605.
Kubota Y, Folsom AR, Pankow JS, Wagenknecht LE. "Diabetes-related factors and abdominal aortic aneurysm events: the Atherosclerotic Risk in Communities Study." Ann Epidemiol. 2018;28(2):102-106.e1.
Kubota Y, Cushman M, Zakai N, Rosamond WD. "TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study." J Thromb Thrombolysis. 2018;45(3):353-359.
Kubota Y, Chen LYee, Whitsel EA. "Heart rate variability and lifetime risk of cardiovascular disease: the Atherosclerosis Risk in Communities Study." Ann Epidemiol. 2017;27(10):619-625.e2.
Kubota Y, Folsom AR, Matsushita K, Couper DJ. "Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study." Atherosclerosis. 2018;268:225-230.
Kubota Y, Alonso A, Shah AM, Chen LYee. "Television Watching as Sedentary Behavior and Atrial Fibrillation: The Atherosclerosis Risk in Communities Study." J Phys Act Health. 2018;15(12):895-899.
Kubota Y, McAdams-DeMarco M. "Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study." Thromb Res. 2016;144:144-8.
Kubota Y, Alonso A, Heckbert SR, Norby FL. "Homocysteine and Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities Study and the Multi-Ethnic Study of Atherosclerosis." Heart Lung Circ. 2019;28(4):615-622.
Kubota Y, Alonso A. "β-Thromboglobulin and incident cardiovascular disease risk: The Atherosclerosis Risk in Communities study." Thromb Res. 2017;155:116-120.
Kubota Y, Heiss G, Maclehose RF, Roetker NS. "Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study." JAMA Intern Med. 2017;177(8):1165-1172.
Kucharska-Newton AM, Rosamond WD, Mink PJ, Alberg AJ, Shahar E, Folsom AR. "HDL-cholesterol and incidence of breast cancer in the ARIC cohort study." Ann Epidemiol. 2008;18(9):671-7.
Kucharska-Newton AM, Harald K, Rosamond WD, Rose KM, Rea TD, Salomaa V. "Socioeconomic indicators and the risk of acute coronary heart disease events: comparison of population-based data from the United States and Finland." Ann Epidemiol. 2011;21(8):572-9.
Kucharska-Newton AMaria, Griswold M, Yao ZHoward, et al. "Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study." J Am Heart Assoc. 2017;6(3).
Kucharska-Newton AM, Rosamond WD, Schroeder JC, McNeill A M, Coresh J, Folsom AR. "HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study." Lung Cancer. 2008;61(3):292-300.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Kucharska-Newton AMaria, Williams JE, Chang PP, Stearns SC, Sueta CA, Blecker SB. "Anger proneness, gender, and the risk of heart failure." J Card Fail. 2014;20(12):1020-6.
Kucharska-Newton AMaria, Palta P, Burgard S, et al. "Operationalizing Frailty in the Atherosclerosis Risk in Communities Study Cohort." J Gerontol A Biol Sci Med Sci. 2017;72(3):382-388.
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study." Acta Diabetol. 2010;47 Suppl 1:161-8.
Kucharska-Newton AM, Loop MShane, Bullo M, et al. "Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study." Int J Cardiol. 2022;348:152-156.
Kucharska-Newton AMaria, Heiss G, Ni H, Stearns SC, Puccinelli-Ortega N, Wruck LM. "Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study." J Card Fail. 2016;22(1):48-55.
Kucharska-Newton AM, Monda KL, Campbell S, et al. "Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2011;216(1):151-6.
Kucharska-Newton AM, Monda KL, Bielinski SJ, et al. "Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study." J Obes. 2010;2010.
Kulkarni M, Foraker RE, McNeill AM, et al. "Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants." Diabetes Obes Metab. 2017;19(9):1260-1266.
Kummer AE, Grams M, Lutsey PL, et al. "Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study." Clin J Am Soc Nephrol. 2015;10(11):2023-9.
Kunkle BW, Grenier-Boley B, Sims R, et al. "Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing." Nat Genet. 2019;51(3):414-430.
Kwon Y, Norby FL, Jensen PN, et al. "Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)." PLoS One. 2016;11(1):e0147065.
Kwong AM, Blackwell TW, LeFaive J, et al. "Robust, flexible, and scalable tests for Hardy-Weinberg equilibrium across diverse ancestries." Genetics. 2021;218(1).
Kytömaa S, Hegde S, Claggett B, et al. "Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study." JAMA Cardiol. 2019;4(4):363-369.
L
Lacy ME, Wellenius GA, Carnethon MR, et al. "Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study." Diabetes Care. 2016;39(2):285-91.
Lagou V, Mägi R, Hottenga J-Jan, et al. "Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability." Nat Commun. 2021;12(1):24.
Lalani SR, Liu P, Rosenfeld JA, et al. "Recurrent Muscle Weakness with Rhabdomyolysis, Metabolic Crises, and Cardiac Arrhythmia Due to Bi-allelic TANGO2 Mutations." Am J Hum Genet. 2016;98(2):347-57.
Lamichhane AP, Couper DJ, Jenkins GP. "Longitudinal Associations Between Body Mass Index During Young Adulthood, Subsequent Weight Change, and Incident Diabetes During Mid- and Older-Adulthood in Non-Hispanic White and African American Populations: The Atherosclerosis Risk in Communities Study." Metab Syndr Relat Disord. 2020;18(7):313-320.
Lamprea-Montealegre JA, Sharrett ARichey, Matsushita K, Selvin E, Szklo M. "Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study." Atherosclerosis. 2014;234(1):42-6.
Lange LA, Hu Y, Zhang H, et al. "Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol." Am J Hum Genet. 2014;94(2):233-45.
Larson N, Hutchinson R, Boerwinkle E. "Lack of association of 3 functional gene variants with hypertension in African Americans." Hypertension. 2000;35(6):1297-300.
Larsson SC, Traylor M, Burgess S, Boncoraglio GB, Jern C, Michaëlsson K. "Serum magnesium and calcium levels in relation to ischemic stroke: Mendelian randomization study." Neurology. 2019;92(9):e944-e950.
Laudenslager M, Lazo M, Wang D, et al. "Association between the soluble receptor for advanced glycation end products (sRAGE) and NAFLD in participants in the Atherosclerosis Risk in Communities Study." Dig Liver Dis. 2021.
Lawani SO, Demerath EW, Norby FL, Soliman EZ, Huxley RR, Rose KM. "Birth weight and the risk of atrial fibrillation in whites and African Americans: the Atherosclerosis Risk In Communities (ARIC) study." BMC Cardiovasc Disord. 2014;14:69.
Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh JJ. "Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease." JAMA Intern Med. 2016;176(2):238-46.
Lazarus B, Wu A, Shin J-I, et al. "Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study." JAMA Intern Med. 2018;178(7):903-910.
Lazo M, Halushka MK, Shen L, et al. "Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study." Am Heart J. 2015;170(5):961-7.
Lazo M, Rubin J, Clark JM, et al. "The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease." J Hepatol. 2015;62(4):841-7.
Lazo M, Chen Y, McEvoy JW, et al. "Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study." Clin Chem. 2016;62(9):1202-10.
Lazo M, Young HJ, Brancati FL, et al. "NH2-terminal pro-brain natriuretic peptide and risk of diabetes." Diabetes. 2013;62(9):3189-93.
Lee AK, Rawlings AM, Lee CJ, et al. "Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study." Diabetologia. 2018;61(9):1956-1965.
Lee C D, Folsom AR, Pankow JS, Brancati FL. "Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction." Circulation. 2004;109(7):855-60.
Lee MJeong, Deal JA, Ramulu PY, Sharrett ARichey. "Prevalence of Retinal Signs and Association With Cognitive Status: The ARIC Neurocognitive Study." J Am Geriatr Soc. 2019;67(6):1197-1203.
Lee CR, North KE, Bray MS, et al. "Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study." Hum Mol Genet. 2006;15(10):1640-9.
Lee CMan Ying, Colagiuri S, Woodward M, et al. "Comparing different definitions of prediabetes with subsequent risk of diabetes: an individual participant data meta-analysis involving 76 513 individuals and 8208 cases of incident diabetes." BMJ Open Diabetes Res Care. 2019;7(1):e000794.
Lee CR, North KE, Bray MS, et al. "NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities study." Pharmacogenet Genomics. 2006;16(12):891-9.

Pages